Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination
Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
Study carried out in the Clinical and Analytical Unit of the Department of Pharmacology and
Toxicology of the Faculty of Medicine of the Universidad Autómoma de Nuevo León, with the
objective of comparing the bioavailability (Cmax, AUC) of an oral formulation containing
Etoricoxib 90 mg / Tramadol 50 mg in combination with that of two oral formulations,
Etoricoxib 90 mg or Tramdol 50 mg, administered as a single dose, in healthy subjects under
fasting conditions.